These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma? Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646 [TBL] [Abstract][Full Text] [Related]
3. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival. Chen CA; Cheng WF; Lee CN; Chen TM; Kung CC; Hsieh FJ; Hsieh CY Gynecol Oncol; 1999 Aug; 74(2):235-40. PubMed ID: 10419737 [TBL] [Abstract][Full Text] [Related]
4. Angiogenesis and other markers for prediction of survival in metastatic renal cell carcinoma. Alamdari FI; Rasmuson T; Grankvist K; Ljungberg B Scand J Urol Nephrol; 2007; 41(1):5-9. PubMed ID: 17366095 [TBL] [Abstract][Full Text] [Related]
5. Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group. Schips L; Dalpiaz O; Lipsky K; Langner C; Rehak P; Puerstner P; Pummer K; Zigeuner R Eur Urol; 2007 Jan; 51(1):168-73; discussion 174. PubMed ID: 16844285 [TBL] [Abstract][Full Text] [Related]
6. Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma. Ljungberg BJ; Jacobsen J; Rudolfsson SH; Lindh G; Grankvist K; Rasmuson T BJU Int; 2006 Sep; 98(3):661-7. PubMed ID: 16925769 [TBL] [Abstract][Full Text] [Related]
7. Angiogenic factors: vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) are not necessarily elevated in patients with advanced renal cell carcinoma. Edgren M; Lennernäs B; Larsson A; Kälkner KM Anticancer Res; 2001; 21(2B):1423-9. PubMed ID: 11396226 [TBL] [Abstract][Full Text] [Related]
8. A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis. Braybrooke JP; O'Byrne KJ; Propper DJ; Blann A; Saunders M; Dobbs N; Han C; Woodhull J; Mitchell K; Crew J; Smith K; Stephens R; Ganesan TS; Talbot DC; Harris AL Clin Cancer Res; 2000 Dec; 6(12):4697-704. PubMed ID: 11156222 [TBL] [Abstract][Full Text] [Related]
9. Serum concentrations of vascular endothelial growth factor in vulvar cancer. Hefler L; Tempfer C; Obermair A; Frischmuth K; Sliutz G; Reinthaller A; Leodolter S; Kainz C Clin Cancer Res; 1999 Oct; 5(10):2806-9. PubMed ID: 10537345 [TBL] [Abstract][Full Text] [Related]
10. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma. Shang ZJ; Li JR; Li ZB Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6--from the Groupe Francais d'Immunotherapie. Negrier S; Perol D; Menetrier-Caux C; Escudier B; Pallardy M; Ravaud A; Douillard JY; Chevreau C; Lasset C; Blay JY; J Clin Oncol; 2004 Jun; 22(12):2371-8. PubMed ID: 15197198 [TBL] [Abstract][Full Text] [Related]
12. Serum levels of vascular endothelial growth factor as a prognostic factor in bladder cancer. Bernardini S; Fauconnet S; Chabannes E; Henry PC; Adessi G; Bittard H J Urol; 2001 Oct; 166(4):1275-9. PubMed ID: 11547057 [TBL] [Abstract][Full Text] [Related]
13. Different isoform patterns for vascular endothelial growth factor between clear cell and papillary renal cell carcinoma. Jacobsen J; Grankvist K; Rasmuson T; Ljungberg B BJU Int; 2006 May; 97(5):1102-8. PubMed ID: 16643499 [TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of serum vascular endothelial growth factor in ovarian cancer. Oehler MK; Caffier H Anticancer Res; 2000; 20(6D):5109-12. PubMed ID: 11326678 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480. George DJ; Halabi S; Shepard TF; Vogelzang NJ; Hayes DF; Small EJ; Kantoff PW; Clin Cancer Res; 2001 Jul; 7(7):1932-6. PubMed ID: 11448906 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma. Yildiz E; Gokce G; Kilicarslan H; Ayan S; Goze OF; Gultekin EY BJU Int; 2004 May; 93(7):1087-93. PubMed ID: 15142169 [TBL] [Abstract][Full Text] [Related]
18. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes. Aguayo A; Kantarjian HM; Estey EH; Giles FJ; Verstovsek S; Manshouri T; Gidel C; O'Brien S; Keating MJ; Albitar M Cancer; 2002 Nov; 95(9):1923-30. PubMed ID: 12404286 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma. Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951 [TBL] [Abstract][Full Text] [Related]
20. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis. Tamura M; Ohta Y Cancer; 2003 Sep; 98(6):1217-22. PubMed ID: 12973845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]